Immunocore to present at upcoming investor conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Mizuho Downgrades Immunocore Holdings (IMCR) to Neutral
November 11, 2024 5:47 AM ESTMizuho analyst Graig Suvannavejh downgraded Immunocore Holdings (NASDAQ: IMCR) from Outperform to Neutral with a price target of $38.00 (from $72.00).
The analyst comments "Following IMCR's 3Q24 update last week, we downgrade IMCR to Neutral from Outperform and lower our 12-month PT 47% to $38 from $72.... More
